KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $34.25 $64.70 Friday, 26th Apr 2024 ALPN stock ended at $64.56. This is 0.0929% less than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 0.186% from a day low at $64.51 to a day high of $64.63.
90 days $24.56 $64.70
52 weeks $6.71 $64.70

Historical Alpine Immune Sciences Inc prices

Date Open High Low Close Volume
Mar 21, 2024 $40.51 $42.88 $40.23 $41.60 971 569
Mar 20, 2024 $40.26 $41.79 $39.73 $40.23 1 240 019
Mar 19, 2024 $37.40 $42.24 $37.15 $39.95 3 004 463
Mar 18, 2024 $36.46 $36.49 $35.00 $35.47 916 917
Mar 15, 2024 $35.92 $37.37 $35.59 $36.38 3 340 524
Mar 14, 2024 $36.21 $37.00 $34.90 $35.89 1 365 088
Mar 13, 2024 $36.44 $37.52 $36.05 $36.61 746 994
Mar 12, 2024 $36.34 $37.48 $35.61 $36.45 1 005 676
Mar 11, 2024 $35.72 $37.18 $35.29 $35.38 1 128 574
Mar 08, 2024 $37.52 $38.12 $35.52 $35.93 1 255 744
Mar 07, 2024 $38.91 $39.27 $36.71 $37.00 1 031 483
Mar 06, 2024 $38.30 $38.74 $37.84 $38.55 715 715
Mar 05, 2024 $36.40 $38.02 $36.26 $37.47 1 700 096
Mar 04, 2024 $36.60 $37.00 $35.01 $36.66 1 240 363
Mar 01, 2024 $35.45 $36.57 $35.36 $36.00 986 967
Feb 29, 2024 $35.63 $35.63 $34.62 $35.22 709 465
Feb 28, 2024 $35.67 $36.16 $34.62 $34.92 548 572
Feb 27, 2024 $35.01 $36.70 $34.99 $35.96 964 922
Feb 26, 2024 $33.92 $34.93 $33.72 $34.75 771 135
Feb 23, 2024 $33.19 $33.99 $32.39 $33.92 722 761
Feb 22, 2024 $30.89 $33.48 $30.59 $33.11 1 078 308
Feb 21, 2024 $30.38 $30.72 $29.56 $30.39 521 792
Feb 20, 2024 $31.14 $31.48 $29.80 $30.51 1 319 296
Feb 16, 2024 $29.74 $32.13 $29.48 $31.26 1 473 528
Feb 15, 2024 $30.25 $30.77 $29.31 $29.88 628 494
Click to get the best stock tips daily for free!

About Alpine Immune Sciences Inc

Alpine Immune Sciences Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28) antagonist program for the treatment of autoimmune and inflammatory diseases; ALPN-202, a conditional... ALPN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT